Major opioid maker to pay for overdose-antidote development

One of the major opioid manufacturing companies accused of deceptively marketing their drugs – Purdue Pharma – is making a $3.4 million grant to produce the overdose-reversing drug naloxone. “Governments are asking for changes in how opioids are marketed, and for help paying for treatment and the costs of ambulance runs, child welfare systems, jails and other expenses associated with the opioid crisis.”

Leave a Reply

Your email address will not be published. Required fields are marked *